nicotine transdermal system
nicotine transdermal system is a pharmaceutical drug with 7 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Analysis of Aldehyde Biomarkers of Exposure and Host Response
Validation of Biomarkers of Exposure and Host Response
Comparing Smoking Treatment Programs for Lighter Smokers - 1
Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
Clinical Trials (7)
Analysis of Aldehyde Biomarkers of Exposure and Host Response
Validation of Biomarkers of Exposure and Host Response
Comparing Smoking Treatment Programs for Lighter Smokers - 1
Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2
Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7